NCT05779839 · ACTIVE NOT RECRUITING

A Study of Caregiver Connections Via Technology in Dementia

This trial is testing whether a technology-based matching program can connect dementia caregivers with peer support partners more effectively than random matching. Caregivers are paired using either a smart algorithm or a random process, and researchers measure which approach better reduces stress and improves wellbeing. This is a Phase NA behavioral study, meaning it is evaluating a support tool, not a drug or medical treatment.

You may qualify if

  • The participant must have a family member that has been diagnosed with one of the following forms of dementia: Parkinson's/Lewy body dementia, any frontotemporal lobar degeneration dementia, or Alzheimer's dementia.
  • The participant must identify as a care partner or caregiver who has contact with their loved one with dementia, in person or by phone, and provides social/emotional support and full or partial assistance with daily activities at least 3 days per week.
  • The participant must have been caring for their loved one with dementia for at least 3 months.
  • All participants must have access to a computer and be able to use the internet.
  • All participants must be English speaking.
  • All participants must agree to participate in the 15-month study, which includes completing questionnaires, brief "virtual" interactions with the study coordinator quarterly, and actively interacting with the website and potential matches.
  • All participants must agree to follow-up contact throughout the duration of the study, which is anticipated to last 3 years.

You're excluded if

  • Caregiver's loved one does not have a confirmed diagnosis of dementia.
  • Caregiver is unable to provide consent.
  • Caregiver was or has been in that role for less than 3 months.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-05-28

View full record on ClinicalTrials.gov

All APOE4 clinical trials